Published in BMC Cell Biol on February 17, 2005
The extracellular matrix: not just pretty fibrils. Science (2009) 8.52
Overview of the matrisome--an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol (2012) 2.26
Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res (2006) 2.08
The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol (2013) 1.73
Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis (2009) 1.58
Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev Biol (2007) 1.38
Angiogenesis. Cold Spring Harb Perspect Biol (2011) 1.37
αV integrins in angiogenesis and cancer. Cold Spring Harb Perspect Med (2011) 1.33
Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys (2008) 1.31
Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery. Tissue Eng Part A (2010) 1.25
Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol Cell Biol (2010) 1.20
Biomaterials that regulate growth factor activity via bioinspired interactions. Adv Funct Mater (2011) 1.16
Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion. Mol Cancer Res (2008) 1.15
Integrins as "functional hubs" in the regulation of pathological angiogenesis. Semin Cancer Biol (2009) 1.05
Fibronectin growth factor-binding domains are required for fibroblast survival. J Invest Dermatol (2010) 1.02
Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. BMC Cell Biol (2006) 1.02
Fibronectin at select sites binds multiple growth factors and enhances their activity: expansion of the collaborative ECM-GF paradigm. J Invest Dermatol (2013) 1.01
Cilostazol activates function of bone marrow-derived endothelial progenitor cell for re-endothelialization in a carotid balloon injury model. PLoS One (2011) 1.00
Evolving the use of peptides as components of biomaterials. Biomaterials (2011) 0.99
Gene transcriptional networks integrate microenvironmental signals in human breast cancer. Integr Biol (Camb) (2010) 0.96
BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape. J Invest Dermatol (2015) 0.91
A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2013) 0.90
Collagen IX is required for the integrity of collagen II fibrils and the regulation of vascular plexus formation in zebrafish caudal fins. Dev Biol (2009) 0.89
Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration. J Biol Chem (2012) 0.86
Biological assessment of a calcium silicate incorporated hydroxyapatite-gelatin nanocomposite: a comparison to decellularized bone matrix. Biomed Res Int (2014) 0.86
Enter the matrix: shape, signal and superhighway. FEBS J (2013) 0.84
Vascular tube formation on matrix metalloproteinase-1-damaged collagen. Br J Cancer (2008) 0.84
Assembly of human organs from stem cells to study liver disease. Am J Pathol (2013) 0.83
Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer. Cancer Cell Int (2013) 0.83
Mechanochemical regulation of growth cone motility. Front Cell Neurosci (2015) 0.80
Fibronectin Interaction and Enhancement of Growth Factors: Importance for Wound Healing. Adv Wound Care (New Rochelle) (2015) 0.79
Protein-hydrogel interactions in tissue engineering: mechanisms and applications. Tissue Eng Part B Rev (2012) 0.78
Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix. Cell Biol Int (2007) 0.78
Synergistic effect of fibronectin and hepatocyte growth factor on stable cell-matrix adhesion, re-endothelialization, and reconstitution in developing tissue-engineered heart valves. Heart Vessels (2007) 0.77
Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease. Am J Physiol Renal Physiol (2011) 0.77
Towards integrating extracellular matrix and immunological pathways. Cytokine (2017) 0.76
Effect of vitronectin bound to insulin-like growth factor-I and insulin-like growth factor binding protein-3 on porcine enamel organ-derived epithelial cells. Int J Dent (2012) 0.76
Tuning cell migration: contractility as an integrator of intracellular signals from multiple cues. F1000Res (2016) 0.76
Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers. Adv Wound Care (New Rochelle) (2015) 0.75
Decellularized bone matrix grafts for calvaria regeneration. J Tissue Eng (2016) 0.75
HGF potentiates extracellular matrix-driven migration of human myoblasts: involvement of matrix metalloproteinases and MAPK/ERK pathway. Skelet Muscle (2017) 0.75
Competitive Protein Binding Influences Heparin-Based Modulation of Spatial Growth Factor Delivery for Bone Regeneration. Tissue Eng Part A (2017) 0.75
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature (1994) 10.34
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell (1997) 6.55
Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res (1977) 5.19
Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer (2002) 5.02
Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J Cell Biol (1996) 4.21
Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J (1996) 3.99
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J (1999) 2.92
A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell (2001) 2.62
Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J (1997) 2.40
Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc Natl Acad Sci U S A (1997) 1.98
Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J Cell Biol (2003) 1.93
Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci U S A (2003) 1.90
Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res (2002) 1.76
Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Cell Biol (2003) 1.75
Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem (2001) 1.72
The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration. J Cell Sci (1998) 1.70
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65
Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol (2001) 1.64
Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. J Biol Chem (2000) 1.52
Apoptotic cues from the extracellular matrix: regulators of angiogenesis. Oncogene (2003) 1.41
A molecular mechanism of integrin crosstalk: alphavbeta3 suppression of calcium/calmodulin-dependent protein kinase II regulates alpha5beta1 function. J Cell Biol (1999) 1.38
Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem (2002) 1.37
Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J Vasc Surg (2004) 1.27
Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation (2003) 1.12
Interaction of Ras with phosphoinositide 3-kinase gamma. Biochem J (1997) 1.05
CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J Biol Chem (2003) 1.04
Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp Hematol (1998) 0.99
Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression. Cardiovasc Res (2002) 0.98
Mechanisms of hepatocyte growth factor-mediated vascular smooth muscle cell migration. Circ Res (2003) 0.92
HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cells. Int J Cancer (1999) 0.90
Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res (2006) 2.08
Is cytochrome modulation the new frontier for decreasing the risk of cataract? Indian J Pharmacol (2009) 1.90
Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res (2002) 1.76
Heparin modulates the conformation and signaling of platelet integrin αIIbβ3. Thromb Res (2011) 1.39
Popliteal vascular injury during total knee arthroplasty. J Surg Res (2003) 1.28
Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J Vasc Surg (2004) 1.27
Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis. Development (2011) 1.13
Immobilization and clustering of structurally defined oligosaccharides for sugar chips: an improved method for surface plasmon resonance analysis of protein-carbohydrate interactions. Bioconjug Chem (2006) 1.13
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 1.08
Sugar Chips immobilized with synthetic sulfated disaccharides of heparin/heparan sulfate partial structure. Bioorg Med Chem Lett (2008) 0.89
Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells. Biochem Biophys Res Commun (2012) 0.88
A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts. J Vasc Surg (2013) 0.87
Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis. Atherosclerosis (2011) 0.86
Vascular graft healing. III. FTIR analysis of ePTFE graft samples from implanted bigrafts. J Biomed Mater Res B Appl Biomater (2004) 0.84
Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity. J Cell Biochem (2010) 0.84
Heparin modulates integrin-mediated cellular adhesion: specificity of interactions with alpha and beta integrin subunits. Cell Commun Adhes (2003) 0.82
Survival after lower-extremity amputation. J Am Coll Surg (2004) 0.82
An initial experience of 100 paediatric laparoscopic nephrectomies with transperitoneal or posterior prone retroperitoneoscopic approach. Pediatr Surg Int (2007) 0.82
Circulating inflammatory cells are associated with vein graft stenosis. J Vasc Surg (2011) 0.81
The telecommunication revolution in the medical field: present applications and future perspective. Curr Surg (2004) 0.81
Evaluation of bronchodilator and anti-anaphylactic activity of Myrica sapida. Iran Biomed J (2008) 0.80
Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist. Eur J Pharmacol (2010) 0.79
Sildenafil in the Treatment of SSRI-Induced Sexual Dysfunction: A Pilot Study. Prim Care Companion J Clin Psychiatry (1999) 0.77
Randomized trial of harp therapy during in vitro fertilization-embryo transfer. J Evid Based Complementary Altern Med (2013) 0.77
Anticoagulants: to bleed or not to bleed, that is the question. Semin Vasc Surg (2002) 0.77
High-sensitivity analysis of naturally occurring sugar chains, using a novel fluorescent linker molecule. J Biochem (2009) 0.77
Management of gastroesophageal reflux associated with malrotation in children. J Pediatr Surg (2011) 0.76
Towards the assembly of heparin and heparan sulfate oligosaccharide libraries: efficient synthesis of uronic acid and disaccharide building blocks. Tetrahedron (2010) 0.76
Protein fragments from the VEGF binding domain of fibronectin are expressed in distinct spatial and temporal patterns during venous thrombus resolution. Thromb Res (2012) 0.76
Enhancement of capillary and cellular ingrowth in ePTFE implants with a proangiogenic recombinant construct derived from fibronectin. J Biomed Mater Res A (2010) 0.75
Authors' reply. Indian J Pharmacol (2009) 0.75
Authors' reply. Indian J Pharmacol (2009) 0.75
Therapeutic potential of novel modulators of neovascularization. Future Cardiol (2008) 0.75
Solitary pulmonary infantile hemangioma in an infant with atrial septal defect. Pediatr Dev Pathol (2007) 0.75
Validated HPTLC method for quantitative determination of gallic acid in stem bark of Myrica esculenta Buch.-Ham. ex D. Don, myricaceae. J AOAC Int (2010) 0.75